Cancer Surgery Cost Not Linked with Hospital Volume

Share this content:
Medicare payments influenced by postoperative complications, cost of index hospitalization.
Medicare payments influenced by postoperative complications, cost of index hospitalization.

Hospital surgical volume does not appear to correlate with Medicare payments for cancer surgery, according to research published in the Journal of Clinical Oncology.

Hari Nathan, M.D., Ph.D., of the Memorial Sloan Kettering Cancer Center in New York City, and colleagues assessed risk-adjusted 30-day episode Medicare payments for elderly patients undergoing cancer surgery. The relationship between hospital volume and payments was evaluated.

The researchers found differences between the first and third terciles of cost, ranging from 27 percent for cystectomy to 40 percent for colectomy. Most of the variation in cost (66 to 82 percent) was attributed to the cost of the index hospitalization, and not costs related to readmissions or physician services.

RELATED: Unplanned Hospitalizations for Gastrointestinal Cancers Common

Neither total risk-adjusted payments nor complication rates were associated with hospital volume. Complication rates were associated with 47 to 70 percent higher costs.

"Cost was strongly associated with postoperative complications and primarily driven by differences in the cost of the index hospitalization," the authors write. "Efforts to prevent and cost-effectively manage complications are more likely to reduce costs than volume-based referral of cancer surgery alone."

One author disclosed financial ties to Genentech.

Reference

  1. Nathan, Hari, et al. "Hospital Volume, Complications, and Cost of Cancer Surgery in the Elderly." Journal of Clinical Oncology. doi: 10.1200/JCO.2014.57.7155. November 24, 2014.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs